[144] Scansource Inc SEC Filing

Rhea-AI Filing Summary

Form 144 summary for Scansource, Inc. (SCSC): The filer proposes to sell 4,402 shares of Scansource common stock through Merrill Lynch on 08/27/2025 on NASDAQ. The reported aggregate market value of the shares to be sold is $190,474.54 based on 21,884,508 shares outstanding. These shares were acquired through restricted stock unit vesting on 08/25/2025 (1,012 shares), 08/26/2025 (1,080 shares), 08/27/2025 (1,214 shares), and 08/30/2025 (1,096 shares), with compensatory payment noted at each vesting date. The filer also reported a prior sale by Rachel Hayden of 6,738 shares on 06/20/2025 for gross proceeds of $278,077.26. The filer attests there is no material nonpublic information.

Insights

Financial Analyst

TL;DR: Routine insider sale under Rule 144; modest size relative to shares outstanding, appears procedural rather than market-moving.

The filing documents a proposed sale of 4,402 shares valued at $190,474.54 to occur through Merrill Lynch on NASDAQ on 08/27/2025. The shares originate from recent RSU vesting events across four dates and are described as compensatory payments. Given the company's outstanding share count of 21,884,508, the transaction represents a small fraction of total equity and is consistent with routine insider liquidity following compensation vesting. The filing also discloses a prior insider sale of 6,738 shares on 06/20/2025 for $278,077.26. No earnings, debt, or operational metrics are provided in this notice to assess broader financial impact.

Corporate Governance Expert

TL;DR: Compliance-focused filing documenting RSU-derived share sales; it affirms Rule 144 procedures and insider attestation regarding material nonpublic information.

The notice shows adherence to Rule 144 procedures by identifying the broker, proposed sale date, share counts, acquisition method, and previous insider sales. Acquisition details specify that all 4,402 shares arose from restricted stock unit vesting and were treated as compensatory payments on the listed dates, which is standard for executive or employee equity compensation. The signer asserts no undisclosed material adverse information, a required certification for such notices. This is a routine governance disclosure rather than a corporate event requiring material investor action.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
COMMON	MERRILL LYNCH 3455 PEACHTREE RD NE SUITE 1000 ATLANTA GA 30326	4402	190474.54	21884508	08/27/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
COMMON	08/25/2025	RESTRICTED STOCK UNIT VEST	SCANSOURCE, INC			1012	08/25/2025	COMPENSATORY PAYMENT
COMMON	08/26/2025	RESTRICTED STOCK UNIT VEST	SCANSOURCE, INC			1080	08/26/2025	COMPENSATORY PAYMENT
COMMON	08/27/2025	RESTRICTED STOCK UNIT VEST	SCANSOURCE, INC			1214	08/27/2025	COMPENSATORY PAYMENT
COMMON	08/30/2025	RESTRICTED STOCK UNIT VEST	SCANSOURCE, INC			1096	08/30/2025	COMPENSATORY PAYMENT

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
RACHEL HAYDEN 6 LOGUE COURT GREENVILLE SC 29615	COMMON	06/20/2025	6738	278077.26

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for Scansource (SCSC) report?

The form reports a proposed sale of 4,402 common shares through Merrill Lynch on 08/27/2025 with an aggregate market value of $190,474.54.

How were the 4,402 shares acquired according to the filing?

All 4,402 shares were acquired from restricted stock unit vesting on 08/25/2025, 08/26/2025, 08/27/2025, and 08/30/2025 and listed as compensatory payments.

Does the filing disclose any recent insider sales for Scansource (SCSC)?

Yes. The filing discloses a prior sale by Rachel Hayden of 6,738 shares on 06/20/2025 for gross proceeds of $278,077.26.

Which broker and exchange are involved in the proposed sale?

The broker is Merrill Lynch (address listed in the filing) and the sale is planned on the NASDAQ exchange.

What certification does the filer make on the Form 144?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.